Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Among various techniques of regional anesthesia, peripheral nerve blocks (PNB) consist in anesthetizing only one single limb or one specific anatomical area. A huge body of scientific evidence now demonstrates that PNBs are of major interest during perioperative patient care in many surgical specialties. As a matter of fact, PNBs are even frequently superior to general anesthesia. The most important benefits of PNBs are found in outpatient surgery (1), in orthopedic surgery (2), but also in improving the overall quality of postoperative analgesia (3), at rest but especially during mobilization (i.e. long lasting blocks, perineural catheters).
However, the PNB techniques require expertise and technical skills, since it is necessary to inject the local anesthetic in close vicinity of nerve trunks or nerve roots in order to interrupt the nerve impulses.
The overall safety of these techniques requires mastering all potential complications, which, although exceptional, can be major when they occur (i.e. nerve lesion, seizure, cardiac arrest, to name only the most serious). These complications may be caused either by a mechanical trauma (nerve damage by the needle), or by toxicity of the administered local anesthetic (all local anesthetics show neurological toxicity, and some also cardiac toxicity). To summarize, safety in regional anesthesia requires the ability to avoid injecting local anesthetic intraneurally as well as intravascularly, and in reducing the injected doses.
Historically speaking, PNBs were initially performed using a blind technique (seeking paresthesias), then more recently using nerve stimulation, and since now a decade by using ultrasound guidance (USG).
Ultrasound-guided regional anesthesia (USGRA) has allowed reaching the safety standards and reducing complications as never before (4). When using US-guidance the anesthesiologist is able to identify the various anatomical structures and thus adapt the procedure to inter-individual anatomy. Furthermore, US-guidance allows real-time needle guidance and assessment of local anesthetic spread around neural structures. Visualizing the spread of local anesthetic allows a rapid and early diagnosis of intravascular or intraneural injection too. There is now also scientific evidence that US-guidance decreases the number of vascular punctures, as well as reduces the injected volumes of local anesthetics, while increasing the overall success rate of PNBs. Moreover, USGRA improves the patient comfort (5).
Ultrasonography is now part of the everyday tools for the anesthesiologist. This bedside technology is useful not only for regional anesthesia, but also for placing peripheral and central venous access with a reduced risk of complications, for bedside assessment of gastric emptiness before the induction of a general anesthesia, or for an early assessment of severe trauma patients (i.e. FAST protocols) (6). Ultrasonography is also a major tool in intensive care units (i.e. cardiac and thoracic ultrasonography). Putting all this together, it is no longer possible to imagine working as an anesthesiologist without having an immediate access to bedside high quality ultrasonography.
Ultrasound devices designed for the operating theatre must provide high quality of images, as well as the usual US modes (i.e. B, PW, CFM,
Radiologists at Belgium
The many advances in cardiovascular diagnostic imaging technology, interventional procedures, drug development and elucidation of risk factors have resulted in a steady reduction in deaths from cardiovascular disease in most European countries. However CVD still remains the leading cause of mortality in Europe, with an annual toll of 4.3 million deaths, and experts predict that, with the ageing population as well as lifestyle changes that are increasing the prevalence of obesity and Type 2 diabetes, we are now facing a CVD epidemic that could overwhelm our health services.
Because of effective dissemination of information on CVD, people are increasingly aware of the modifiable risk factors, which include tobacco use and excessive alcohol consumption, a paucity of suitable exercise and a high fat and sugar diet. Many patients also know that statins, which reduce Low-Density Lipoprotein Cholesterol levels, can be taken for primary prevention of CVD; some even expect these drugs on demand. Indeed over 10% of UK residents now take statins, and The National Institute for Health and Care Excellence (NICE) is currently updating its guidelines to recommend statin therapy if the assessed risk of developing CVD within 10 years is 10% (the previous guidelines stated 20%). The American Heart Association and American College of Cardiology
Worldwide breast cancer is the most common female cancer; in the West one in eight women eventually develop the disease. However the mortality rate has steadily decreased in recent decades, in large part due to improved screening programmes and earlier detection. The current gold standard screening tool is mammography, but in 2011 the FDA approved the first Digital Breast Tomosynthesis (DBT) system, and this or similar systems are now available in a limited number of Western hospitals, generating studies to compare the effectiveness of the two imaging modalities.
Healthcare professionals are cognizant with the limitations of mammography, particularly for imaging dense breasts. X-rays of each breast from different angles can only provide a 2D image of a 3D structure, and normal breast tissue can thus mask a tumour. In addition false positive results augment both patient anxiety and hospital workload. And patients are well aware (even if many male health professionals are not) that the compression necessary for allowing the whole breast to be adequately viewed during mammography is not merely
Anesthesiologists face a daunting task keeping up and adapting their practice to cope with the incessant advances in surgery, and to innovations within their own discipline.
Today
April 2024
The medical devices information portal connecting healthcare professionals to global vendors
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy